Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study

Autor: Wechsler, Michael E, Menzies-Gow, Andrew, Brightling, Christopher E, Kuna, Piotr, Korn, Stephanie, Welte, Tobias, Griffiths, Janet M, Sałapa, Kinga, Hellqvist, Åsa, Almqvist, Gun, Lal, Harbans, Kaur, Primal, Skärby, Tor, Colice, Gene, Cambursano, Victor H, Fernandez, Marcelo J, Scherbovsky, Fernando D, Yanez, Anahi, Tolcachier, Alberto J, Stok, Ana M, Verra, Fernando J B, Korn, Stephanie, Forster, Karin, Rolke, Mathias, Ludwig-Sengpiel, Andrea, Schmoller, Tibor, Schmidt, Olaf, Milger-Kneidinger, Katrin, Hoffmann, Martin, Temme, Hilke, Linnhoff, Anneliese, Welte, Tobias, Kirschner, Joachim, Kuna, Piotr, Rewerska, Barbara, Pisarczyk-Bogacka, Ewa, Haak Lee, Sang, Jae Lee, Byung, Park, Heung-Woo, Park, Jung-Won, Young Lee, Sook, Sook Cho, You, Ho Lee, Kwan, Bavbek, Sevim, Gemicioglu, Bilun, Ediger, Dane, Koca Kalkan, Ilkay, Hanta, Ismail, Yorgancioglu, Arzu, DytyatkovsKa, Yevgeniya, Mostovoy, Yuriy M, Lebed, Kyrylo, Yakovenko, Oleh, Bernstein, David I, Tillinghast, Jeffrey P, Que, Loretta, Madison, Jan, Rambasek, Todd, Shenoy, Kartik, Thompson, Charles A, Chappel, Christopher M, Hudes, Golda, Sorial, Ehab, Kureishy, Shahrukh A, Rehman, Syed M, Lugogo, Njira, Gonzalez, Erika G, Umeh, Fred C, Boren, Eric J, Sigmon, Jason, Ismail, Hummayun, Mohan, Arjun, Bansal, Sandeep, Kaelin, Thomas D

Publikováno v: The Lancet Respiratory Medicine; July 2022, Vol. 10 Issue: 7 p650-660, 11p